Integrated Diagnostics Holdings PLC IDHC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.53
- Day Range
- $0.52–0.54
- 52-Week Range
- $0.46–0.84
- Bid/Ask
- $0.51 / $0.00
- Shares Outstanding
- 581.33M
- Market Cap
- $305.78M
- Volume/Avg
- 72,253 / 136,307
Key Statistics
- Price/Earnings (Normalized)
- 9.83
- Price/Sales
- 1.64
- Dividend Yield (Trailing)
- 1.62%
- Dividend Yield (Forward)
- 1.62%
- Dividend Payment Schedule
- Jun
- Total Yield
- 1.62%
Company Profile
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments: the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 7,137
- Website
- https://www.idhcorp.com
Valuation
|
Metric
|
IDHC
|
|---|---|
Price/Earnings (Normalized) | 9.83 |
Price/Book Value | 3.29 |
Price/Sales | 1.64 |
Price/Cash Flow | 6.80 |
Price/Earnings
IDHC
Financial Strength
|
Metric
|
IDHC
|
|---|---|
Quick Ratio | 1.35 |
Current Ratio | 1.67 |
Interest Coverage | 9.92 |
Quick Ratio
IDHC
Profitability
|
Metric
|
IDHC
|
|---|---|
Return on Assets (Normalized) | 17.60% |
Return on Equity (Normalized) | 36.68% |
Return on Invested Capital (Normalized) | 26.28% |
Return on Assets
IDHC
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|W>KKwhm< | LOCK|H# | $243B | |||
| Danaher Corp
DHR
| LOCK|&&$&%^WJ | LOCK|!m | $155B | |||
| Agilent Technologies Inc
A
| LOCK|tDSXQXk | LOCK|$> | $48B | |||
| IQVIA Holdings Inc
IQV
| LOCK|%<Gc^d | LOCK|J%#t% | $43B | |||
| Waters Corp
WAT
| LOCK|HG^y<m | LOCK|rF | $43B | |||
| Illumina Inc
ILMN
| LOCK|sMY!#%c | LOCK|&^%&^ | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|#L&@x#p | LOCK|$! | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|V<?l@sB | LOCK|rX%yn | $31B | |||
| Quest Diagnostics Inc
DGX
| LOCK|b>ql^@G | LOCK|$L<? | $25B | |||
| Labcorp Holdings Inc
LH
| LOCK|&RTj@X% | LOCK|$<p^X | $25B |
United States